Loading clinical trials...

Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

Establishment of a Biobank Aimed at Studying Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

NCT07265908•IRCCS San Raffaele

View on ClinicalTrials.gov

Summary

The REPRO-Biobank has been established at San Raffaele Hospital in Milan for the purpose of collecting and preserving human biological samples and associated data. Its primary objective is to support biomedical research, with a particular focus on advancing scientific knowledge - including in the field of genetics - related to gynecological disorders, male and female infertility, and pregnancy-related conditions.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Affected participants
•* Male infertility
•* Female infertility
•* Gynecological disorders
•* Pregnancy-related conditions
•* Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation)
•* Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients
•* Healthy adult subjects (including pregnant and lactating women)
•* Able to give informed consent for participation in the study

Exclusion Criteria

•* Patients unable or unwilling to sign the informed consent
•Patients unable or unwilling to sign the informed consent

Locations (1)

Irccs San Raffaele Hospital

Milan, Milan, Italy

Key Dates

Start Date

April 9, 2024

Primary Completion Date

December 31, 2043

Completion Date

December 31, 2043

Last Updated

December 5, 2025

Enrollment

3,000

ESTIMATED participants

Conditions

Gynecological DisordersMale InfertilityFemale InfertilityPregnancy

Interventions

Blood sampling

OTHER

Efficacy and Safety of a New Sperm Capacitation Method

NCT06742437

Reproductive IssuesMale Infertility+3 more

View study

RECRUITINGPHASE4

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

NCT06921395

Female Infertility

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 5, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

Inclusion Criteria

Exclusion Criteria

Efficacy and Safety of a New Sperm Capacitation Method

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

Study to Verify the Efficacy of a Product Containing 125 mg of TetraSOD® for the Treatment of Male Infertility

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Female Fertility, Environmental Agents and Stress Oxidant

Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment